scispace - formally typeset
J

Joshua A. Horwitz

Researcher at Rockefeller University

Publications -  36
Citations -  4370

Joshua A. Horwitz is an academic researcher from Rockefeller University. The author has contributed to research in topics: Virus & Antibody. The author has an hindex of 22, co-authored 34 publications receiving 3810 citations. Previous affiliations of Joshua A. Horwitz include Cornell University & Harvard University.

Papers
More filters
Journal ArticleDOI

Beyond the Academic Journal: Unfreezing Misconceptions About Mental Illness and Gun Violence Through Knowledge Translation to Decision-Makers.

TL;DR: The recent passage of gun violence prevention legislation in California provides an example of successfully closing the knowledge translation gap between research and decision-making processes.
Posted ContentDOI

Structure of a rabies virus polymerase complex from electron cryo-microscopy

TL;DR: A complete structure of RABV L bound with its phosphoprotein cofactor (P) is described, determined by electron cryo-microscopy at 3.3 Å resolution, which suggests distinct template and product entry and exit pathways during transcription and replication.
Journal ArticleDOI

Visualizing molecular interactions that determine assembly of a bullet-shaped vesicular stomatitis virus particle

TL;DR: In this paper , the structure of intact, infectious VSV particles determined by cryogenic electron microscopy was reconstructed at 3.5 Å resolution, with lower resolution for the rounded tip.
Posted ContentDOI

HIV-1 Vpu restricts Fc-mediated effector functions in vivo

TL;DR: It is found that restoring Vpu expression greatly reduces nnAb recognition of infected cells, rendering them resistant to ADCC responses, highlighting the importance of Vpu-mediated evasion of humoral responses.

Overcoming HIV pathways for escape using rationally-designed anti-HIV antibodies

TL;DR: One mutant, 45-46m2, neutralizes 96% of HIV strains in a cross-clade panel and viruses isolated from an HIV-infected individual that are resistant to all other known bNAbs, making it the single most broad and potent anti-HIV antibody to date.